false
2023-11-15
0001790169
00-0000000
Flora Growth Corp.
0001790169
2023-11-15
2023-11-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 15, 2023
FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)
|
Ontario
|
001-40397
|
Not Applicable |
| (State or other jurisdiction |
(Commission |
(IRS Employer |
| of incorporation) |
File Number) |
Identification No.) |
3406 SW 26th Terrace, Suite C-1
Fort Lauderdale, Florida, United States
33132
(Address of principal executive offices) (ZIP Code)
Registrant’s telephone number, including area code: (954) 842-4989
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
|
Common Shares, no par value
|
|
FLGC
|
|
NASDAQ Capital Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).
Emerging growth company ☑
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On November 10, 2023, Flora Growth Corp. (the "Company") granted a total of 726,241 Restricted Stock Awards (the "RSAs") after the close of markets to officers and directors of the Company pursuant to its 2022 Equity Compensation Plan. The following schedule summarizes the grants:
| Plan Participant |
Role |
Number of
RSAs granted |
Vesting Date |
| Clifford Starke |
CEO and Director |
327,851 |
November 15, 2023 |
| Dany Vaiman |
CFO |
149,024 |
January 1, 2024 |
| Kevin Taylor |
Chairman |
124,186 |
January 1, 2024 |
| Edward Woo |
Director |
74,512 |
January 1, 2024 |
| Thomas Solomon |
Director |
35,766 |
November 15, 2023 |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 104 |
Cover Page Interactive Data File |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
FLORA GROWTH CORP. |
| |
|
|
| Date: November 15, 2023 |
By: |
/s/ Clifford Starke |
| |
Name: |
Clifford Starke |
| |
Title: |
Chief Executive Officer |